Oxford-based company Exscientia, which develops drugs using artificial intelligence, received $ 1.5 million from the Bill & Melinda Gates Foundation to develop a Covid-19 treatment that will also be effective against new mutations and other Sars viruses.
The company, which receives funding from the Gates Foundation, aims to develop drugs within 12 months and then call volunteers for clinical testing.
According to the news in The Guardian, the company is working on a new blocker class that uses artificial intelligence technology to target the protease enzyme of Sars-CoV-2, thereby preventing the proliferation of the corona virus. The developed blocking molecules will be put in a pill to fight Covid-19. He hopes the treatment will also be effective in new mutations and other corona viruses.
The project will include 15 biologists, chemists and artificial intelligence experts.